Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study
Open Access
- 16 October 2015
- journal article
- Published by Elsevier BV in Value in Health
- Vol. 18 (8), 956-968
- https://doi.org/10.1016/j.jval.2015.08.010
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trialBMC Infectious Diseases, 2013
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE StudyBMJ Open, 2012
- Genital Transmission of Human Papillomavirus in Recently Formed Heterosexual CouplesThe Journal of Infectious Diseases, 2011
- The cost‐effectiveness of community‐based screening for oral cancer in high‐risk males in the United States: A Markov decision analysis approachThe Laryngoscope, 2011
- Impact of vaccinating boys and men against HPV in the United StatesVaccine, 2010
- Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysisVaccine, 2010
- Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United StatesBMJ, 2009
- A Multi-Type HPV Transmission ModelBulletin of Mathematical Biology, 2008
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerThe New England Journal of Medicine, 2003